Squadron Master Fund LP on CTNM, Oct 28, 2026

Squadron Master Fund LP now owns 5.1%, as a passive investor.

Date
Oct 28, 2026
Who
Squadron Master Fund LP
Fund
CTNM - Contineum Therapeutics
Stake
5.1% (1,700,000 shares)
Type of notice
Passive investor
Document number
0002050709-26-000029

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to CTNM